Apnimed, Inc.
NASDAQ:APMDBiotechnology
Healthcare
$17.45 +2.84%
+$0.71 today
- Market cap
- $726.46M
- Beta
- 0.00
Volume 0.30M
Average 1.15M
APMD Sales of Investments
Cash received from selling or redeeming investments.
No reported Sales of Investments figures are available to summarize.
Sales of Investments history
Currency unavailable · from the cash flow
No Sales of Investments data reported for this period type.
Sales of Investments vs competitors
How APMD compares with its peers on the latest reported figures
APMD Competitors
| Company | Period | LTM | YoY | 3-year CAGR | % of revenue |
|---|---|---|---|---|---|
| LTM Jun 2026 | $230.16M USD | +54.0% | — | 25.6% | |
| LTM Mar 2026 | €16.78M EUR | -69.1% | +35.5% | 102.9% | |
APMDApnimed, Inc. | — | — | — | — | — |
| Peer median (excluding APMD) | — | -7.6% | +35.5% | 64.2% | |
Competitors are the stored peer set for APMD. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.
Cash Flow Statement
Currency unavailable
Apnimed, Inc.
NASDAQ:APMD
Intrinsic Alpha fair value
Locked
Current Price
$17.45
Unlock the intrinsic value to see where the current price sits on the valuation runway.
Valuation runway
LockedGet the intrinsic value and margin of safety with a free account.
Continue the stock analysis
Jump to another research area for this company.